172 related articles for article (PubMed ID: 37945774)
1. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.
Oldroyd AGS; Callen JP; Chinoy H; Chung L; Fiorentino D; Gordon P; Machado PM; McHugh N; Selva-O'Callaghan A; Schmidt J; Tansley SL; Vleugels RA; Werth VP; ; Aggarwal R
Nat Rev Rheumatol; 2023 Dec; 19(12):805-817. PubMed ID: 37945774
[TBL] [Abstract][Full Text] [Related]
2. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
3. Cancer and myositis: Who, when, and how to screen.
Kardes S; Gupta L; Aggarwal R
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101771. PubMed ID: 35970749
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Yield of Computed Tomography for Cancer Detection in a Tertiary Referral Population of Idiopathic Inflammatory Myositis Patients.
Mecoli CA; Chee B; Chen M; Wang X; Albayda J; Paik JJ; Tiniakou E; Adler B; Kelly W; Mammen AL; Platz EA; Casciola-Rosen L; Christopher-Stine L; Shah AA
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2142-2150. PubMed ID: 36913182
[TBL] [Abstract][Full Text] [Related]
5. Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity.
Zhao L; Su K; Liu T; Sun D; Jiang Z
Clin Rheumatol; 2021 Mar; 40(3):1009-1016. PubMed ID: 32676923
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.
Laporte A; Mariampillai K; Allenbach Y; Pasi N; Donciu V; Toledano D; Granger B; Benveniste O; Grenier PA; Boussouar S
Eur Radiol; 2022 May; 32(5):3480-3489. PubMed ID: 35022809
[TBL] [Abstract][Full Text] [Related]
7. Clinical Value of
Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
Front Immunol; 2021; 12():745211. PubMed ID: 34867971
[TBL] [Abstract][Full Text] [Related]
8. Treatment of dyslipidemia in idiopathic inflammatory myositis: results of the International Myositis Assessment and Clinical Studies Group survey.
Charles-Schoeman C; Amjadi SS; Paulus HE;
Clin Rheumatol; 2012 Aug; 31(8):1163-8. PubMed ID: 22526479
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic inflammatory myositis.
Tieu J; Lundberg IE; Limaye V
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):149-68. PubMed ID: 27421222
[TBL] [Abstract][Full Text] [Related]
11. Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review.
Bentick G; Fairley J; Nadesapillai S; Wicks I; Day J
Semin Arthritis Rheum; 2022 Dec; 57():152107. PubMed ID: 36335683
[TBL] [Abstract][Full Text] [Related]
12. Cancer Screening for Dermatomyositis: A Survey of Indirect Costs, Burden, and Patient Willingness to Pay.
Jicha KI; Bazewicz CG; Helm MF; Butt M; Shumaker K; Foulke GT
Cutis; 2023 Aug; 112(2):89-95. PubMed ID: 37820344
[TBL] [Abstract][Full Text] [Related]
13. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
14. Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies.
Preger C; Notarnicola A; Hellström C; Wigren E; Fernandes-Cerqueira C; Kvarnström M; Wahren-Herlenius M; Idborg H; Lundberg IE; Persson H; Gräslund S; Jakobsson PJ
J Autoimmun; 2023 Jan; 134():102951. PubMed ID: 36470210
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
[TBL] [Abstract][Full Text] [Related]
16. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
[TBL] [Abstract][Full Text] [Related]
17. [Chinese expert-based consensus statement on diagnosis and treatment of idiopathic inflammatory myopathy associated interstitial lung disease].
Respiratory Council of Chinese Research Hospital Association
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):635-650. PubMed ID: 35768372
[TBL] [Abstract][Full Text] [Related]
18. Performance of myositis-specific antibodies detected on myositis line immunoassay to diagnose and sub-classify patients with suspected idiopathic inflammatory myopathy, a retrospective records-based review.
Beaton TJ; Gillis D; Prain K; Morwood K; Anderson J; Goddard J; Baird T
Int J Rheum Dis; 2021 Sep; 24(9):1167-1175. PubMed ID: 34250724
[TBL] [Abstract][Full Text] [Related]
19. Real world utilization of the myositis autoantibody panel.
Maheswaranathan M; Johannemann A; Weiner JJ; Jessee R; Eudy AM; Criscione-Schreiber L
Clin Rheumatol; 2021 Aug; 40(8):3195-3205. PubMed ID: 33629202
[TBL] [Abstract][Full Text] [Related]
20. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]